ARTICLE | Clinical News
Tobramycin inhaled powder: Started Phase III
October 10, 2005 7:00 AM UTC
CHIR started the international, double-blind, placebo-controlled Phase III ASPIRE I trial in 150 patients. CHIR co-developed the inhaler device and the formulation with Nektar Therapeutics (NKTR, San ...